Ftse Mib
34.228,77
0,71%
DAX
18.430,05
1,42%
S&P 500
5.187,10
0,12%
NASDAQ
16.374,67
0,16%
Bitcoin
63.427,97
0,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Alligator Bioscience Ab (0RK9) Alligator Bioscience Ab (0RK9) Notizie

0RK9

Alligator Bioscience Ab (0RK9)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RK9
DataOraFonteTitoloSimboloCompagnia
01/04/202208:20PR Newswire (US)Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort CommencesLSE:0RK9Alligator Bioscience Ab
23/03/202209:07PR Newswire (US)Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kgLSE:0RK9Alligator Bioscience Ab
11/02/202208:23PR Newswire (US)Alligator Bioscience AB: Year End report January-December 2021LSE:0RK9Alligator Bioscience Ab
01/02/202209:16PR Newswire (US)Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
19/01/202208:42PR Newswire (US)Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory BeattyLSE:0RK9Alligator Bioscience Ab
18/01/202208:19PR Newswire (US)Alligator Bioscience Announces OPTIMIZE-1 Trial Update: Cohort Fully Dosed with No Adverse Effects ReportedLSE:0RK9Alligator Bioscience Ab
16/12/202108:41PR Newswire (US)Alligator Bioscience Announces Trial Update and Early Readout for ATOR-1017 Confirming Biomarker, Safety & Tolerability DataLSE:0RK9Alligator Bioscience Ab
15/12/202114:37PR Newswire (US)Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal Nature CommunicationLSE:0RK9Alligator Bioscience Ab
08/11/202117:54PR Newswire (US)Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University RotterdamLSE:0RK9Alligator Bioscience Ab
08/11/202116:59PR Newswire (US)Bulletin from the extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
21/10/202108:45PR Newswire (US)Alligator Bioscience AB: Interim report January-September 2021LSE:0RK9Alligator Bioscience Ab
07/10/202108:25PR Newswire (US)Notice of extraordinary general meeting in Alligator Bioscience ABLSE:0RK9Alligator Bioscience Ab
02/09/202112:17PR Newswire (US)Alligator is exploring financing alternatives to support phase II studies for Mitazalimab, phase II preparations for ATOR-1017 as well as the development of other pipelineLSE:0RK9Alligator Bioscience Ab
02/09/202110:33PR Newswire (US)Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination TherapyLSE:0RK9Alligator Bioscience Ab
18/08/202108:50PR Newswire (US)Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion CorporationLSE:0RK9Alligator Bioscience Ab
16/08/202115:16PR Newswire (US)Alligator Bioscience Announces New Senior Director of Communications & Investor RelationsLSE:0RK9Alligator Bioscience Ab
30/06/202109:10PR Newswire (US)Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical dataLSE:0RK9Alligator Bioscience Ab
07/06/202108:25PR Newswire (US)Article on CD40 agonistic antibodies published in Expert Opinion on Biological TherapyLSE:0RK9Alligator Bioscience Ab
04/06/202108:20PR Newswire (US)Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agonist drug candidate ATOR-1017LSE:0RK9Alligator Bioscience Ab
05/05/202108:23PR Newswire (US)Alligator's mitazalimab shown to enhance cancer vaccineLSE:0RK9Alligator Bioscience Ab
04/05/202108:21PR Newswire (US)Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative fieldLSE:0RK9Alligator Bioscience Ab
27/04/202108:25PR Newswire (US)Alligator Bioscience AB: Interim report January-March 2021LSE:0RK9Alligator Bioscience Ab
22/04/202119:46PR Newswire (US)The Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bi...LSE:0RK9Alligator Bioscience Ab
15/04/202108:21PR Newswire (US)Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel ImmunotherapyLSE:0RK9Alligator Bioscience Ab
03/04/202114:02PR Newswire (US)Alligator Bioscience postpones the Annual General Meeting to June 1, 2021LSE:0RK9Alligator Bioscience Ab
18/03/202119:13PR Newswire (US)Alligator Bioscience appoints Søren Bregenholt as new CEOLSE:0RK9Alligator Bioscience Ab
18/03/202116:40PR Newswire (US)Alligator Bioscience publishes Annual Report for 2020LSE:0RK9Alligator Bioscience Ab
11/03/202108:21PR Newswire (US)Mitazalimab synergizes with chemotherapy - Alligator Bioscience presents new preclinical data at AACRLSE:0RK9Alligator Bioscience Ab
26/02/202108:27PR Newswire (US)Alligator Bioscience AB: Year-end Report January-December 2020LSE:0RK9Alligator Bioscience Ab
23/02/202116:12PR Newswire (US)Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA)LSE:0RK9Alligator Bioscience Ab
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0RK9

La tua Cronologia

BIT
RACE
Ferrari NV
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
LDO
Leonardo
BIT
FBK
Finecobank
BIT
ENI
Eni
BIT
IRE
Iren
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network